NDC properties for "0.4 ML Amjevita 50 MG/ML Prefilled Syringe" (RxCUI 2627717)
About this data
The tables show NDC propoerties for 0.4 ML Amjevita 50 MG/ML Prefilled Syringe with the RxCUI 2627717
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for 0.4 ML Amjevita 50 MG/ML Prefilled Syringe (RxCUI 2627717)
BLA | BLA761024 |
---|---|
MMSL_CODE | BD31315 |
RxCUI | 2627717 |
SPL_SET_ID | 9c44bd5b-4464-40a4-8933-8680950f00f2 |
Prescribable Synonym | AMJEVITA 20 MG in 0.4 ML Prefilled Syringe |
RXNAV_STR | 0.4 ML Amjevita 50 MG/ML Prefilled Syringe |
RxNorm Name | 0.4 ML adalimumab-atto 50 MG/ML Prefilled Syringe [Amjevita] |
RxNorm Synonym | 0.4 ML Amjevita 50 MG/ML Prefilled Syringe |
RxNorm Synonym | Amjevita 20 MG per 0.4 ML Prefilled Syringe |
Related queries | Interactions (for RxCUI 2627717) |
NDC Properties
NDC Item 55513041101
NDC 9 | 55513-411 |
---|---|
NDC 10 | 55513-411-01 |
NDC Item | 55513041101 |
Packaging | 1 SYRINGE in 1 CARTON (55513-411-01) / .4 mL in 1 SYRINGE |
BLA | BLA761024 |
FDA SPL set id | 770230 |
Labeler | Amgen Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | BLA |
Marketing effective time low | 2023-01-31 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55513-411 |